Glimepride And Metformin Hydrochloride 500mg Tablets

GLEXIA - M2 is a highly effective anti-diabetic formulation used for the management of Type 2 Diabetes Mellitus. It combines the dual action of Glimepiride and Metformin to provide better glycemic control by improving insulin secretion and reducing hepatic glucose production.
Composition:

Glimepiride – 2 mg

Metformin Hydrochloride – 500 mg (as per variant)

Key Benefits:

Helps control blood sugar levels effectively

Improves insulin sensitivity

Reduces risk of diabetes-related complications

Suitable for long-term diabetes management

Indication:

Type 2 Diabetes Mellitus (Non-Insulin Dependent Diabetes)

Dosage Form:

Oral Tablets

Packing:

Blister Packaging (as per requirement)

Therapeutic Segment:

Anti-Diabetic

Key Features:

WHO-GMP Certified Manufacturing

High-quality formulation

Competitive pricing for pharma franchise & distribution

Attractive packaging available

Usage:
To be taken as directed by a registered medical practitioner.